China Registration - Approval for Medical Devices in China
This course provides a structured and practice oriented introduction to the regulatory approval of medical devices in China. Participants gain a clear understanding of the NMPA registration process, including classification, registration types, Product Technical Requirements (PTR), clinical evidence pathways, and post market obligations. The training explains how to prepare compliant submissions, manage registration testing, and navigate frequent regulatory updates. Practical examples and real world insights help participants develop effective strategies for market entry and long term compliance in one of the world’s most dynamic healthcare markets.
Course Outline
- Overview of China’s medical device market and regulatory trends
- NMPA regulatory framework and authority structure
- Device classification and registration pathways
- PTR preparation and registration testing
- Clinical evidence requirements and CER preparation
- QMS requirements and inspections
- Post market surveillance
- Labeling, UDI
- Responsibilities of the China Representative
- Practical examples and strategies for successful approval
Learning Outcomes
Overview of the Chinese Medical Device Market
- Current status of the medical device industry in China
- Market dynamics and regulatory trends
Regulatory Framework and Authorities
- Introduction to China’s medical device regulations
- Roles and responsibilities of the NMPA and provincial authorities
Classification and Registration Pathways
- Medical device classification according to NMPA requirements
- Registration pathways and approval processes
- Fast-track registration pathways, including priority review, emergency approval, innovative approval, conditional approval
Product Technical Requirements (PTR) and Registration Testing
- Introduction to Chinese standards
- Purpose, structure and key components of the PTR
- Common challenges in registration testing
Clinical Evidence for NMPA Approval
- Clinical evaluation pathways in China
- Requirements for Clinical Evaluation Reports (CER)
QMS Requirements and Inspections
- QMS requirements for foreign manufacturers
- Inspections and documentation requirements
Post Market Surveillance
- Post market surveillance obligations
- Handling of adverse events and reporting requirements
- Product recall requirements
Labeling and UDI Requirements
- Chinese labeling requirements
- UDI implementation in China
Responsibilities of the China Representative
- Legal responsibilities and liabilities
Who Should Attend
Why You Should Attend
This course is ideal for professionals seeking a clear and actionable understanding of China’s regulatory landscape. It equips participants to classify devices correctly, prepare compliant PTR documents, select the appropriate clinical evaluation pathway, and manage registration testing efficiently. The training provides practical insights into fast track options, QMS expectations, and post market obligations, enabling participants to develop effective strategies for successful NMPA approval and sustainable market access.
Who Should Attend
- Medical device manufacturers
- Regulatory Affairs professionals
- Engineers in the medical device industry
- Quality management personnel
Explore related topics
510(k) Premarket Notification Workshop – Bringing Medical Devices to the U.S. Market
AI Act, MDR/IVDR, QMSR: Practical AI compliance trainings for medical devices
Biological Evaluation of Medical Devices - How to Succeed in Your Notified Body Assessment
CAPA Considerations: A Comprehensive Overview
Change Management in Practice - Selected Practical Examples for Evaluating Changes
Need help choosing?
Our training advisors can help you find the perfect match.